New NICE Guidelines – identification and management of adrenal insufficiency
The publication of new NICE (National Institute for Health and Care Excellence) guidelines – “Adrenal insufficiency: identification and management” marks a significant advancement in the management and treatment of primary, secondary and tertiary adrenal insufficiency.
These guidelines provide updated, evidence-based recommendations designed to improve diagnosis, treatment, and long-term care for individuals with adrenal insufficiency.
By setting clear standards, the new guidelines aim to enhance patient outcomes, ensure timely interventions, and reduce assoicated risks – including that of adrenal crisis.
Read the guidelines on the NICE website here.
Recent Blog Posts
Patient Survey: Improving the Delivery of Genetic Results
CAH is a rare genetic condition and many of us will have received results of genetic testing at some point on our CAH journey. When you received these reults might not have been at the best time - pehaps you received genomic test results while you were driving, on...
Webinar: Finding Your Way – A Parent’s Guide to Rare Disease
Join the NHS South East Genomic Medicine Service and Unique on Wednesday 16th September 2026 at 12-1pm on Teams to celebrate the launch of “Finding Your Way: A Parent's Guide to Rare Disease”. Written by parents, for parents, this new guide offers practical support,...
New report highlights access gap for innovative medicines
The CAH Support Group recently provided input into a new Medicines Australia report about access to innovative medicines in Australia. The report, now published, warns that Australian patients are missing access to some innovative medicines available in comparable...